Skip to content
Recall Observatory FDA recall evidence

Drug product

TAZORAC (tazarotene) Gel 0.05%, Rx only, packaged in 15 x 3.5 g professional sample containers, Manufactured by: Allergan Inc., Irvine, CA 92512. UPC: 300238335159.

D-0100-2017

June 30, 2016

Class II

Product summary

Firm
Allergan Sales, LLC
Event
Event 74623
Status
Terminated
Classification
Class II
Quantity
17,112 tubes
Official record key
drug-enforcement:D-0100-2017

Official wording

Reason: Failed Content Uniformity Specifications

Code information: Lot # 85037; Exp 05/17 Lot # 82583; Exp 10/16

Distribution pattern: Nationwide

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Content Uniformity Specifications